Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Herholz

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|April 3, 2003
[Evaluation of invasive cardiologic procedures]Rainer Schräder, Hans-Friedrich Spies, Harald Herholz
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|July 15, 2003
[Curriculum for "structured medical care"]Maria Eberlein-Gonska, Andreas Löw, Harald Herholz
Medizinische Klinik (Munich, Germany : 1983)|February 23, 2010
[Evaluation of special GP-centered health care contracts in Germany by the participating GPs. present situation and future perspectives]Anja Klingenberg, Björn Broge, Harald Herholz, et al.
Herz|June 26, 2003
[4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002]Benny Levenson, Alexander Albrecht, Stefan Göhring, et al.
Applied Health Economics and Health Policy|October 22, 2016
Ethical Hurdles in the Prioritization of Oncology CareFolkert de Groot, Stefano Capri, Jean-Claude Castanier, et al.
BMC Health Services Research|June 10, 2010
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payersJakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2010
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology|July 3, 2014
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implicationsBrian Godman, Bjorn Wettermark, Menno van Woerkom, et al.
Frontiers in Pharmacology|August 12, 2011
Policies to enhance prescribing efficiency in europe: findings and future implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|April 3, 2003
[Evaluation of invasive cardiologic procedures]Rainer Schräder, Hans-Friedrich Spies, Harald Herholz
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|July 15, 2003
[Curriculum for "structured medical care"]Maria Eberlein-Gonska, Andreas Löw, Harald Herholz
Medizinische Klinik (Munich, Germany : 1983)|February 23, 2010
[Evaluation of special GP-centered health care contracts in Germany by the participating GPs. present situation and future perspectives]Anja Klingenberg, Björn Broge, Harald Herholz, et al.
Herz|June 26, 2003
[4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002]Benny Levenson, Alexander Albrecht, Stefan Göhring, et al.
Applied Health Economics and Health Policy|October 22, 2016
Ethical Hurdles in the Prioritization of Oncology CareFolkert de Groot, Stefano Capri, Jean-Claude Castanier, et al.
BMC Health Services Research|June 10, 2010
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payersJakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2010
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology|July 3, 2014
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implicationsBrian Godman, Bjorn Wettermark, Menno van Woerkom, et al.
Frontiers in Pharmacology|August 12, 2011
Policies to enhance prescribing efficiency in europe: findings and future implicationsBrian Godman, William Shrank, Morten Andersen, et al.
Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Pageof 2